Cargando…

Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors

Despite the burgeoning field of coronavirus disease-19 (COVID-19) research, the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralising antibodies remains unclear. This study validated two high-throughput immunological methods for use as surrogate live virus neutrali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Thomas W., Schulte-Pelkum, Johannes, Steller, Laura, Filchtinski, Daniel, Jenness, Robin, Williams, Michelle R., Kober, Christina, Manni, Sandro, Hauser, Thomas, Hahn, Aaron, Kalina, Uwe, Simon, Toby L., Schuetz, Patrick, Roth, Nathan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489294/ https://www.ncbi.nlm.nih.gov/pubmed/34619377 http://dx.doi.org/10.1016/j.clim.2021.108871

Ejemplares similares

Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
por: Stinca, Sara, et al.
Publicado: (2021)

IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools
por: Kober, Christina, et al.
Publicado: (2022)

Application of the SARS-CoV-2-S1 ACE-2 receptor interaction as the basis of the fully automated assay to detect neutralizing SARS-CoV-2-S1 antibodies in blood samples
por: Filchtinski, Daniel, et al.
Publicado: (2022)

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
por: Bentley, Emma M., et al.
Publicado: (2021)

Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
por: Tonn, Torsten, et al.
Publicado: (2020)

Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
por: Muecksch, Frauke, et al.
Publicado: (2020)

Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
por: Davis, Samantha K, et al.
Publicado: (2022)

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
por: Nguyen, Dung, et al.
Publicado: (2021)

Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients
por: Wong, Ngai Sze, et al.
Publicado: (2022)

Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis
por: Savage, Helen R., et al.
Publicado: (2021)

Comment on Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556
por: Schulte-Pelkum, Johannes
Publicado: (2021)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
por: Harvala, Heli, et al.
Publicado: (2020)

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
por: Cantoni, Diego, et al.
Publicado: (2022)

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
por: Wilhelm, Alexander, et al.
Publicado: (2022)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
por: Coombes, Naomi S., et al.
Publicado: (2023)

Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
por: Andersen, Kylie J., et al.
Publicado: (2020)

Neutralisation pockets and spectral lines
por: Gröbner, Oswald
Publicado: (1972)

On Toxic Neutralisations: II. Reconstitution
por: Richardson, Benjamin Ward
Publicado: (1894)

Mechanisms of Rhinovirus Neutralisation by Antibodies
por: Touabi, Lila, et al.
Publicado: (2021)

Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020
por: Mehew, Jennifer, et al.
Publicado: (2020)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

CHALLENGES IN THE PRODUCTION OF COVID-19 CONVALESCENT PLASMA – ANALYSIS OF DONOR RECRUITMENT
por: Sekiya, E.J., et al.
Publicado: (2020)

Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment
por: Sekiya, Eliseo Joji, et al.
Publicado: (2021)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
por: Bonetti, Tatiana Carvalho de Souza, et al.
Publicado: (2021)

Longitudinal Transcriptional Analysis of Peripheral Blood Leukocytes in COVID Convalescent Donors
por: Gedda, Mallikarjuna Rao, et al.
Publicado: (2021)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

Neutralising Antibodies against Ricin Toxin
por: Prigent, Julie, et al.
Publicado: (2011)

Electron cooling with neutralised electron beams
por: Bosser, Jacques, et al.
Publicado: (1994)

Electron cooling with neutralised electron beams
por: Bosser, J, et al.
Publicado: (1994)

On Toxic Neutralisations: I.—Isomeric Variation
por: Richardson, Benjamin Ward
Publicado: (1894)

Neutralisation of SARS‐CoV‐2 by anatomical embalming solutions
por: Quondamatteo, Fabio, et al.
Publicado: (2021)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection
por: Fazeli, Alieh, et al.
Publicado: (2022)

Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes
por: Jamwal, Abhishek, et al.
Publicado: (2023)

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19
por: So-Osman, Cynthia, et al.
Publicado: (2022)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d2gdosb3m4orvfhfrpe13jdhhv